Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Radiographics ; 19(4): 989-1008, 1999.
Article in English | MEDLINE | ID: mdl-10464805

ABSTRACT

Primary neoplasms of the adrenal cortex are rare in children and differ significantly in epidemiology, clinical characteristics, and biologic features from their counterparts in adults. In children, the inclusive term adrenocortical neoplasm is applied because adrenal adenoma and adrenal carcinoma may be difficult to distinguish histopathologically. Pediatric adrenocortical neoplasms typically occur before 5 years of age, affect young girls more commonly than boys, and are associated with hemihypertrophy and Beckwith-Wiedemann and Li-Fraumeni syndromes. Most children with an adrenocortical neoplasm present with signs and symptoms of endocrine abnormality, including virilization and Cushing syndrome. Cross-sectional imaging studies typically demonstrate a large, circumscribed, predominantly solid suprarenal mass with variable heterogeneity due to hemorrhage and necrosis. Calcification is not uncommon. Local invasion and metastases to the lungs, liver, and regional lymph nodes may be present at diagnosis. When friable tumor thrombus extends into the inferior vena cava, it poses a high risk of pulmonary embolization. The finding of increased retroperitoneal fat due to hypercortisolism on computed tomographic and magnetic resonance images of children with an adrenal mass favors the diagnosis of adrenocortical neoplasm. Surgical resection is the mainstay of therapy, with chemotherapy used for patients with metastases or persistent elevated hormone levels following surgery. Patients younger than 5 years with aggressive adrenocortical neoplasms fare better than older children.


Subject(s)
Adrenal Cortex Neoplasms/pathology , Diagnostic Imaging , Adolescent , Adrenal Cortex Neoplasms/complications , Adrenal Cortex Neoplasms/diagnosis , Child , Child, Preschool , Diagnosis, Differential , Female , Humans , Infant , Male
2.
Pediatr Dev Pathol ; 2(3): 236-43, 1999.
Article in English | MEDLINE | ID: mdl-10191347

ABSTRACT

This review examines 197 cases of fibrous hamartoma of infancy (FHI) described in the literature and provides a detailed clinicopathologic analysis of what is known to date of this peculiar lesion of the subcutis and lower dermis. The vast majority of these cases occurred within the first year of life (91%). Twenty-three percent were congenital. There was a predilection for boys with a male/female ratio of 2.4. Males and females had similar anatomic distribution with the most common locations being the axillary region, upper arm, upper trunk, inguinal region, and external genital area. Most cases presented as solitary masses, but four cases of multiple separate synchronous lesions have been reported. Most lesions presented as a painless nodule, sometimes with rapid growth. A few cases had overlying skin changes, including alteration in pigmentation, eccrine gland hyperplasia, and increased hair. No lesions were reported to have familial or syndromic association, or to occur in combination with other hamartomas. Spontaneous regression has not been reported. The treatment of choice is local excision. Even with incomplete excision, FHI has a low recurrence rate. Criteria for histologic diagnosis include the presence of well-defined bundles of dense, uniform, fibrous connective tissue projecting into fat, primitive mesenchyme arranged in nests, concentric whorls or bands, and mature adipose tissue intimately admixed with the other components. Flow-cytometric and conventional cytogenetic studies have not been reported; these may clarify any relationship to other fibroblastic/myofibroblastic proliferations in children, resulting in better classification and terminology of this unique lesion.


Subject(s)
Hamartoma/pathology , Child , Child, Preschool , Female , Follow-Up Studies , Forecasting , Humans , Immunohistochemistry , Infant , Infant, Newborn , Male , Microscopy, Electron , Recurrence
3.
Radiographics ; 17(4): 919-37, 1997.
Article in English | MEDLINE | ID: mdl-9225391

ABSTRACT

Rhabdomyosarcoma is the most common tumor of the lower genitourinary tract in children in the first 2 decades of life. Most cases of genitourinary rhabdomyosarcoma are of the embryonal histologic subtype and include tumors of the bladder, prostate, testes and paratesticular sites, penis, perineum, vagina, and uterus. The natural history, pattern of metastatic spread, treatment, and prognosis of childhood rhabdomyosarcoma vary with the anatomic site of the lesion. In children with rhabdomyosarcoma of the bladder or prostate, presenting signs and symptoms include urinary or fecal retention, dysuria, urinary tract infection, and hematuria. Paratesticular rhabdomyosarcoma produces painless scrotal swelling, which may be ignored until the tumor has reached a large size. Vaginal tumors may manifest as a prolapsing mass in the introitus. Radiologic studies of children with genitourinary rhabdomyosarcoma reflect the nonspecific gross features of the tumor, which may be ill defined with infiltrative margins or well circumscribed by a pseudocapsule of compressed tissue. The botryoid variant of embryonal rhabdomyosarcoma results when submucosal tumor produces a polypoid mass resembling a cluster of grapes within a hollow structure. Botryoid morphology is characteristic, but not specific, for rhabdomyosarcoma within the vagina or urinary bladder, since yolk sac tumor and "tumoral" cystitis may have a similar appearance. Invasion of adjacent structures by the primary tumor may make the precise anatomic origin of genitourinary rhabdomyosarcoma difficult to determine on cross-sectional images. Recent refinements in multidisciplinary therapeutic regimens combining chemotherapy, radiation therapy, and surgery have dramatically improved outcome for children with genitourinary rhabdomyosarcoma. Diagnostic imaging plays an important role in monitoring response to therapy.


Subject(s)
Rhabdomyosarcoma/diagnostic imaging , Urogenital Neoplasms/diagnostic imaging , Adolescent , Child , Child, Preschool , Female , Humans , Infant , Magnetic Resonance Imaging , Male , Radiography , Rhabdomyosarcoma/diagnosis , Rhabdomyosarcoma/pathology , Ultrasonography , Urogenital Neoplasms/diagnosis , Urogenital Neoplasms/pathology
4.
Radiographics ; 16(1): 131-48, 1996 Jan.
Article in English | MEDLINE | ID: mdl-10946695

ABSTRACT

Gestational trophoblastic disease (GTD) is a manifestation of an aberrant fertilization event that leads to a proliferative process and, potentially, to an invasive neoplasm. The spectrum of GTD includes hydatidiform moles (complete and partial), invasive mole, choriocarcinoma, and placental site trophoblastic disease (rare). Increased levels of human chorionic gonadotropin (beta-hCG) are associated with all forms. Ultrasonography (US), performed late in the first trimester of a pregnancy complicated by hyperemesis gravidarum, toxemia, or bleeding, is essential in the early detection of hydatidiform mole, the most common form of GTD (80% of cases). In these cases, US typically reveals a central heterogeneous mass with anechoic spaces, which correspond to hydropic villi. In cases of invasive mole, imaging may show a central uterine process (similar to that seen in noninvasive moles), occasionally with myometrial invasion. Choriocarcinoma is often seen as a mass enlarging the uterus, with a heterogeneity that correlates with necrosis and hemorrhage. Because of the widespread availability of serum measurement of beta-hCG, diagnosis of the more severe, persistent manifestations of GTD seldom depends on radiologic examinations. However, imaging studies may alert the referring physician to the diagnosis in cases of early disease. Also, imaging studies may have a problem-solving role in examining patients with recurrent GTD or a confusing clinical picture.


Subject(s)
Trophoblastic Neoplasms/diagnosis , Uterine Neoplasms/diagnosis , Brain Neoplasms/secondary , Chorionic Gonadotropin/blood , Female , Humans , Magnetic Resonance Imaging , Pregnancy , Tomography, X-Ray Computed , Trophoblastic Neoplasms/diagnostic imaging , Trophoblastic Neoplasms/pathology , Ultrasonography, Prenatal , Uterine Neoplasms/diagnostic imaging , Uterine Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...